

Is Caplyta in shortage in 2026? Get the latest update on Caplyta availability, cost, and what patients can do to find it in stock near them.
If you've had trouble filling your Caplyta (Lumateperone) prescription recently, you might be wondering: is there a Caplyta shortage? It's a valid question — and you deserve a clear answer.
Here's what's happening with Caplyta availability in 2026, why you might be having trouble finding it, and what you can do right now.
As of early 2026, Caplyta is not listed on the FDA or ASHP drug shortage databases. That means there is no official, nationwide shortage of the medication. The manufacturer — Intra-Cellular Therapies, now part of Johnson & Johnson — continues to produce and distribute Caplyta.
However, many patients are still reporting difficulty finding it at their local pharmacy. This disconnect between "no official shortage" and "I can't find it anywhere" is common with expensive brand-name specialty medications.
Even without a formal shortage, several factors make Caplyta difficult to locate:
For a more detailed explanation, read our article on why Caplyta is so hard to find.
The cost of Caplyta depends on your insurance coverage:
For more ways to reduce your costs, see our complete guide on how to save money on Caplyta.
The landscape for Caplyta and similar medications is evolving:
Here are the most effective steps you can take right now:
For more tips, read our detailed guide on how to find Caplyta in stock near you.
Caplyta is not in a formal shortage in 2026, but real-world availability challenges continue for many patients. The combination of brand-only status, increased demand from the new MDD approval, high cost, and insurance barriers means finding Caplyta requires some extra effort.
Start with Medfinder to check availability, explore savings options, and work closely with your doctor and pharmacist. You have more options than you might think.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.